Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
7353 | 1377 | 30.9 | 51% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
109 | 3 | RECTAL CANCER//COLORECTAL CANCER//COLONOSCOPY | 71522 |
1176 | 2 | THYMIDYLATE SYNTHASE//THYMIDINE PHOSPHORYLASE//5 FLUOROURACIL | 9333 |
7353 | 1 | URIDINE PHOSPHORYLASE//5 PHENYLTHIOACYCLOURIDINE//LEUCOVORIN | 1377 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | URIDINE PHOSPHORYLASE | authKW | 546617 | 3% | 57% | 43 |
2 | 5 PHENYLTHIOACYCLOURIDINE | authKW | 133042 | 0% | 100% | 6 |
3 | LEUCOVORIN | authKW | 112608 | 4% | 10% | 52 |
4 | PALA | authKW | 99766 | 1% | 38% | 12 |
5 | ALPHA D RIBOSE 1 PHOSPHATE | authKW | 88694 | 0% | 100% | 4 |
6 | BIOCHEMICAL MODULATION | authKW | 76620 | 2% | 16% | 22 |
7 | 5 FLUOROURACIL | authKW | 68192 | 8% | 3% | 116 |
8 | 5 PHENYLSELENENYLACYCLOURIDINE | authKW | 66521 | 0% | 100% | 3 |
9 | FDCYD | authKW | 66521 | 0% | 100% | 3 |
10 | URIDINE PHOSPHORYLASE INHIBITOR | authKW | 66521 | 0% | 100% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 14587 | 53% | 0% | 730 |
2 | Pharmacology & Pharmacy | 2439 | 26% | 0% | 359 |
3 | Biochemistry & Molecular Biology | 258 | 16% | 0% | 216 |
4 | Biophysics | 148 | 5% | 0% | 67 |
5 | Chemistry, Medicinal | 44 | 2% | 0% | 34 |
6 | Biochemical Research Methods | 38 | 3% | 0% | 38 |
7 | Crystallography | 21 | 2% | 0% | 24 |
8 | Chemistry, Analytical | 6 | 3% | 0% | 35 |
9 | Hematology | 5 | 1% | 0% | 20 |
10 | Medicine, Research & Experimental | 1 | 2% | 0% | 23 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BIOL BIOCIENCIAS RIO CLARO | 22174 | 0% | 100% | 1 |
2 | BRAIN KOREA CHUNGBUK BIOMED SCI 21 | 22174 | 0% | 100% | 1 |
3 | CANC THER EUT DRUG DISCOVERY PROGRAM | 22174 | 0% | 100% | 1 |
4 | CHEM S HIROMACHI 1258 SHINAGAWA KU | 22174 | 0% | 100% | 1 |
5 | CLIN CANC NURSING SERV | 22174 | 0% | 100% | 1 |
6 | CLIN PHARMACOL BRANCH CANC TREATMENT | 22174 | 0% | 100% | 1 |
7 | COMPREHENS CANC K4 666 | 22174 | 0% | 100% | 1 |
8 | CORP DEV UBE | 22174 | 0% | 100% | 1 |
9 | FARMACIOL | 22174 | 0% | 100% | 1 |
10 | GALEN FARM TECNOL FARMACEUT | 22174 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CANCER TREATMENT REPORTS | 38623 | 5% | 3% | 62 |
2 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 17390 | 6% | 1% | 76 |
3 | CANCER RESEARCH | 9070 | 9% | 0% | 127 |
4 | BIOCHEMICAL PHARMACOLOGY | 7599 | 6% | 0% | 80 |
5 | EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 7322 | 2% | 1% | 25 |
6 | AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 3971 | 2% | 1% | 27 |
7 | SELECTIVE CANCER THERAPEUTICS | 3266 | 0% | 5% | 3 |
8 | CHEMIOTERAPIA | 3030 | 1% | 2% | 7 |
9 | INVESTIGATIONAL NEW DRUGS | 2785 | 1% | 1% | 18 |
10 | CANCER COMMUNICATIONS | 1951 | 0% | 3% | 3 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | URIDINE PHOSPHORYLASE | 546617 | 3% | 57% | 43 | Search URIDINE+PHOSPHORYLASE | Search URIDINE+PHOSPHORYLASE |
2 | 5 PHENYLTHIOACYCLOURIDINE | 133042 | 0% | 100% | 6 | Search 5+PHENYLTHIOACYCLOURIDINE | Search 5+PHENYLTHIOACYCLOURIDINE |
3 | LEUCOVORIN | 112608 | 4% | 10% | 52 | Search LEUCOVORIN | Search LEUCOVORIN |
4 | PALA | 99766 | 1% | 38% | 12 | Search PALA | Search PALA |
5 | ALPHA D RIBOSE 1 PHOSPHATE | 88694 | 0% | 100% | 4 | Search ALPHA+D+RIBOSE+1+PHOSPHATE | Search ALPHA+D+RIBOSE+1+PHOSPHATE |
6 | BIOCHEMICAL MODULATION | 76620 | 2% | 16% | 22 | Search BIOCHEMICAL+MODULATION | Search BIOCHEMICAL+MODULATION |
7 | 5 FLUOROURACIL | 68192 | 8% | 3% | 116 | Search 5+FLUOROURACIL | Search 5+FLUOROURACIL |
8 | 5 PHENYLSELENENYLACYCLOURIDINE | 66521 | 0% | 100% | 3 | Search 5+PHENYLSELENENYLACYCLOURIDINE | Search 5+PHENYLSELENENYLACYCLOURIDINE |
9 | FDCYD | 66521 | 0% | 100% | 3 | Search FDCYD | Search FDCYD |
10 | URIDINE PHOSPHORYLASE INHIBITOR | 66521 | 0% | 100% | 3 | Search URIDINE+PHOSPHORYLASE+INHIBITOR | Search URIDINE+PHOSPHORYLASE+INHIBITOR |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | AL SAFARJALANI, ON , RAIS, R , NAGUIB, FNM , EL KOUNI, MH , (2012) POTENT COMBINATION THERAPY FOR HUMAN BREAST TUMORS WITH HIGH DOSES OF 5-FLUOROURACIL: REMISSION AND LACK OF HOST TOXICITY.CANCER CHEMOTHERAPY AND PHARMACOLOGY. VOL. 69. ISSUE 6. P. 1449 -1455 | 44 | 96% | 3 |
2 | AL SAFARJALANI, ON , RAIS, R , SHI, JX , SCHINAZI, RF , NAGUIB, FNM , EL KOUNI, MH , (2006) MODULATION OF 5-FLUOROURACIL HOST-TOXICITY AND CHEMOTHERAPEUTIC EFFICACY AGAINST HUMAN COLON TUMORS BY 5-(PHENYLTHIO)ACYCLOURIDINE, A URIDINE PHOSPHORYLASE INHIBITOR.CANCER CHEMOTHERAPY AND PHARMACOLOGY. VOL. 58. ISSUE 5. P. 692-698 | 44 | 94% | 9 |
3 | AL SAFARJALANI, ON , ZHOU, XJ , RAIS, RH , SHI, JX , SCHINAZI, RF , NAGUIB, FNM , EL KOUNI, MH , (2005) 5-(PHENYLTHIO)ACYCLOURIDINE: A POWERFUL ENHANCER OF ORAL URIDINE BIOAVAILABILITY: RELEVANCE TO CHEMOTHERAPY WITH 5-FLUOROURACIL AND OTHER URIDINE RESCUE REGIMENS.CANCER CHEMOTHERAPY AND PHARMACOLOGY. VOL. 55. ISSUE 6. P. 541 -551 | 49 | 77% | 32 |
4 | PARKER, WB , CHENG, YC , (1990) METABOLISM AND MECHANISM OF ACTION OF 5-FLUOROURACIL.PHARMACOLOGY & THERAPEUTICS. VOL. 48. ISSUE 3. P. 381-395 | 71 | 70% | 229 |
5 | LASHKOV, AA , ZHUKHLISTOVA, NE , SEREGINA, TA , GABDULKHAKOV, AG , MIKHAILOV, AM , (2011) URIDINE PHOSPHORYLASE IN BIOMEDICAL, STRUCTURAL, AND FUNCTIONAL ASPECTS: A REVIEW.CRYSTALLOGRAPHY REPORTS. VOL. 56. ISSUE 4. P. 560-589 | 47 | 66% | 4 |
6 | GREM, JL , KING, SA , ODWYER, PJ , LEYLANDJONES, B , (1988) BIOCHEMISTRY AND CLINICAL ACTIVITY OF N-(PHOSPHONACETYL)-L-ASPARTATE - A REVIEW.CANCER RESEARCH. VOL. 48. ISSUE 16. P. 4441-4454 | 84 | 76% | 64 |
7 | WECKBECKER, G , (1991) BIOCHEMICAL PHARMACOLOGY AND ANALYSIS OF FLUOROPYRIMIDINES ALONE AND IN COMBINATION WITH MODULATORS.PHARMACOLOGY & THERAPEUTICS. VOL. 50. ISSUE 3. P. 367-424 | 114 | 44% | 83 |
8 | ODWYER, PJ , (1990) THE ROLE OF LOW-DOSE PALA IN BIOCHEMICAL MODULATION.PHARMACOLOGY & THERAPEUTICS. VOL. 48. ISSUE 3. P. 371-380 | 64 | 89% | 8 |
9 | AL SAFARJALANI, ON , ZHOU, XJ , NAGUIB, FNM , SHI, JX , SCHINAZI, RF , EL KOUNI, MH , (2001) ENHANCEMENT OF THE BIOAVAILABILITY OF ORAL URIDINE BY COADMINISTRATION OF 5-(PHENYLTHIO) ACYCLOURIDINE, A URIDINE PHOSPHORYLASE INHIBITOR: IMPLICATIONS FOR URIDINE RESCUE REGIMENS IN CHEMOTHERAPY.CANCER CHEMOTHERAPY AND PHARMACOLOGY. VOL. 48. ISSUE 5. P. 389-397 | 44 | 79% | 7 |
10 | ASHOUR, OM , NAGUIB, FNM , GOUDGAON, NM , SCHINAZI, RF , EL KOUNI, MH , (2000) EFFECT OF 5-(PHENYLSELENENYL)ACYCLOURIDINE, AN INHIBITOR OF URIDINE PHOSPHORYLASE, ON PLASMA CONCENTRATION OF URIDINE RELEASED FROM 2 ',3 ',5 '-TRI-O-ACETYLURIDINE, A PRODRUG OF URIDINE: RELEVANCE TO URIDINE RESCUE IN CHEMOTHERAPY.CANCER CHEMOTHERAPY AND PHARMACOLOGY. VOL. 46. ISSUE 3. P. 235-240 | 36 | 92% | 5 |
Classes with closest relation at Level 1 |